索引超出了数组界限。
[1] Nestelberger T, Lange R, Kühne M, et al. Calcified epicardial
fat necrosis causing epicardial constriction[J]. Eur Heart J,
2019, 40(45):3698.
[2] Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular
disease: revisiting an old relationship[J]. Metabolism, 2019,
92:98-107.
[3] Packer M. Epicardial adipose tissue may mediate deleterious
effects of obesity and inflammation on the myocardium[J]. J
Am Coll Cardiol, 2018, 71(20):2360-2372.
[4] Parisi V, Rengo G, Perrone-Filardi P, et al. Increased epicardial
adipose tissue volume correlates with cardiac sympathetic
denervation in patients with heart failure[J]. Circ Res, 2016,
118(8):1244-1253.
[5] Larsson SC. Causal association between adiposity and
cardiovascular disease[J]. Eur Heart J, 2019, 40(35):2937-
2938.
[6] Aryana A, Tung R, D'avila A. Percutaneous epicardial
approach to catheter ablation of cardiac arrhythmias[J]. JACC
Clin Electrophysiol, 2020, 6(1):1-20.
[7] Jhuo SJ, Hsieh TJ, Tang WH, et al. The association of the
amounts of epicardial fat, P wave duration, and PR interval in
electrocardiogram[J]. J Electrocardiol, 2018, 51(4):645-651.
[8] Abed HS, Nelson AJ, Richardson JD, et al. Impact of weight
reduction on pericardial adipose tissue and cardiac structure in
patients with atrial fibrillation[J]. Am Heart J, 2015, 169(5):
655-662.
[9] Tam WC, Lin YK, Chan WP, et al. Pericardial fat is associated
with the risk of ventricular arrhythmia in Asian patients[J].
Circ J, 2016, 80(8):1726-1733.
[10] K?r?? A, Turan O, K?r?? G, et al. The relationship between
epicardial fat tissue thickness and frequent ventricular
premature beats[J]. Kardiol Pol, 2015, 73(7):527-532.
[11] Wu CK, Tsai HY, Su MY, et al. Pericardial fat is associated
with ventricular tachyarrhythmia and mortality in patients with
systolic heart failure[J]. Atherosclerosis, 2015, 241(2):607-
614.
[12] Aryana A, D'avila A. Epicardial approach for cardiac
electrophysiology procedures[J]. J Cardiovasc Electrophysiol,
2020, 31(1):345-359.
[13] Zheng H, Liu X, Li Y, et al. A hypothalamic leptin-glutamate
interaction in the regulation of sympathetic nerve activity[J].
Neural Plast, 2017, 2017:2361675.
[14] Yu L, Wang Y, Zhou X, et al. Leptin injection into the left
stellate ganglion augments ischemia-related ventricular
arrhythmias via sympathetic nerve activation[J]. Heart
Rhythm, 2018, 15(4):597-606.
[15] Zeng W, Pirzgalska RM, Pereira MM, et al. Sympathetic
neuro-adipose connections mediate leptin-driven lipolysis[J].
Cell, 2015, 163(1):84-94.
[16] Fukui A, Ikebe-Ebata Y, Kondo H, et al. Hyperleptinemia
exacerbates high-fat diet-mediated atrial fibrosis and
fibrillation[J]. J Cardiovasc Electrophysiol, 2017, 28(6):702-
710.
[17] Zhou M, Wang H, Chen J, et al. Epicardial adipose tissue and
atrial fibrillation: possible mechanisms, potential therapies,
and future directions[J]. Pacing Clin Electrophysiol, 2020,
43(1):133-145.
[18] Yc L, Huang J, Hileman S, et al. Leptin decreases heart rate
associated with increased ventricular repolarization via its
receptor[J]. Am J Physiol Heart Circ Physiol, 2015, 309(10):
H1731-H1739.
[19] Mohseni Z, Derksen E, Oben J, et al. Cardiac dysfunction after
preeclampsia; an overview of pro- and anti-fibrotic circulating
effector molecules[J]. Pregnancy Hypertens, 2021, 23:140-
154.
[20] Li G, Liu T. The therapeutic strategies of enhancing
adiponectin and lowering leptin May be benefit to controlling
atrial fibrillation[J]. Med Hypotheses, 2009, 73(1):122.
[21] Hernández-Romero D, Jover E, Marín F, et al. The prognostic
role of the adiponectin levels in atrial fibrillation[J]. Eur J Clin
Invest, 2013, 43(2):168-173.
[22] Kourliouros A, Karastergiou K, Nowell J, et al. Protective
effect of epicardial adiponectin on atrial fibrillation following
cardiac surgery[J]. Eur J Cardiothorac Surg, 2011, 39(2):228-
232.
[23] Macheret F, Bartz TM, Djousse L, et al. Higher circulating
adiponectin levels are associated with increased risk of atrial
fibrillation in older adults[J]. Heart, 2015, 101(17):1368-1374.
[24] Kim TH, Lee JS, Uhm JS, et al. High circulating adiponectin
level is associated with poor clinical outcome after catheter
ablation for paroxysmal atrial fibrillation[J]. Europace, 2018,
20(8):1287-1293.
[25] Shibata R, Sato K, Pimentel DR, et al. Adiponectin protects
against myocardial ischemia-reperfusion injury through
AMPK- and COX-2-dependent mechanisms[J]. Nat Med,
2005, 11(10):1096-1103.
[26] Acquarone E, Monacelli F, Borghi R, et al. Resistin: a
reappraisal[J]. Mech Ageing Dev, 2019, 178:46-63.
[27] Habeeballah H, Alsuhaymi N, Stebbing MJ, et al. Effects of
central administration of resistin on renal sympathetic nerve
activity in rats fed a high-fat diet: a comparison with leptin[J].
J Neuroendocrinol, 2017, 29(8):e12495.
[28] Berezin AE, Berezin AA, Lichtenauer M. Emerging role of
adipocyte dysfunction in inducing heart failure among obese
patients with prediabetes and known diabetes mellitus[J].
Front Cardiovasc Med, 2020, 7:583175.
[29] Rienstra M, Sun JX, Lubitz SA, et al. Plasma resistin,
adiponectin, and risk of incident atrial fibrillation: the
Framingham Offspring Study[J]. Am Heart J, 2012, 163(1):
119-124.
[30] Gungor H, Ayik MF, Kirilmaz B, et al. Serum resistin level:
as a predictor of atrial fibrillation after coronary artery bypass
graft surgery[J]. Coron Artery Dis, 2011, 22(7):484-490.
[31] Tao S, Huang YQ, Cai AP, et al. Association of serum
omentin-1 concentrations with the presence of atrial
fibrillation[J]. Med Sci Monit, 2016, 22:4749-4754.